These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 26017274)

  • 1. Clopidogrel use and cancer-specific mortality: a population-based cohort study of colorectal, breast and prostate cancer patients.
    Hicks BM; Murray LJ; Hughes C; Cardwell CR
    Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):830-40. PubMed ID: 26017274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drugs affecting the renin-angiotensin system and survival from cancer: a population based study of breast, colorectal and prostate cancer patient cohorts.
    Cardwell CR; Mc Menamin ÚC; Hicks BM; Hughes C; Cantwell MM; Murray LJ
    BMC Med; 2014 Feb; 12():28. PubMed ID: 24521426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of warfarin therapy on breast, colorectal, lung, and prostate cancer survival: a population-based cohort study using the Clinical Practice Research Datalink.
    O'Rorke MA; Murray LJ; Hughes CM; Cantwell MM; Cardwell CR
    Cancer Causes Control; 2015 Mar; 26(3):355-66. PubMed ID: 25534917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5α-Reductase Inhibitors and the Risk of Cancer-Related Mortality in Men With Prostate Cancer.
    Azoulay L; Eberg M; Benayoun S; Pollak M
    JAMA Oncol; 2015 Jun; 1(3):314-20. PubMed ID: 26181177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK.
    Kowall B; Stang A; Rathmann W; Kostev K
    Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):865-74. PubMed ID: 26132313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of statins and the risk of death in patients with prostate cancer.
    Yu O; Eberg M; Benayoun S; Aprikian A; Batist G; Suissa S; Azoulay L
    J Clin Oncol; 2014 Jan; 32(1):5-11. PubMed ID: 24190110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digoxin use after diagnosis of breast cancer and survival: a population-based cohort study.
    Karasneh RA; Murray LJ; Mc Menamin ÚC; Hughes CM; Cardwell CR
    Breast Cancer Res Treat; 2015 Jun; 151(3):661-9. PubMed ID: 25975954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-diagnostic oral bisphosphonate use and colorectal cancer mortality: a population-based cohort study within the UK Clinical Practice Research Datalink.
    Hicks BM; Murray LJ; Hughes C; Cardwell CR
    Br J Cancer; 2015 Jun; 113(1):123-6. PubMed ID: 25989268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digoxin use after diagnosis of colorectal cancer and survival: a population-based cohort study.
    Karasneh RA; Murray LJ; Hughes CM; Cardwell CR
    Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1804-7. PubMed ID: 26364159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin use and survival after colorectal cancer: A population-based cohort study.
    Mc Menamin ÚC; Murray LJ; Hughes CM; Cardwell CR
    Int J Cancer; 2016 Jan; 138(2):369-79. PubMed ID: 26331456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Use of Telmisartan and the Incidence of Cancer.
    Tascilar K; Azoulay L; Dell'Aniello S; Bartels DB; Suissa S
    Am J Hypertens; 2016 Dec; 29(12):1358-1365. PubMed ID: 27557862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin use after diagnosis of breast cancer and survival: a population-based cohort study.
    Cardwell CR; Hicks BM; Hughes C; Murray LJ
    Epidemiology; 2015 Jan; 26(1):68-78. PubMed ID: 25304447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged clopidogrel use after bare metal and drug-eluting stent placement: the Veterans Administration drug-eluting stent study.
    Faxon DP; Lawler E; Young M; Gaziano M; Kinlay S
    Circ Cardiovasc Interv; 2012 Jun; 5(3):372-80. PubMed ID: 22668555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre- and Post-diagnosis Diabetes as a Risk Factor for All-Cause and Cancer-Specific Mortality in Breast, Prostate, and Colorectal Cancer Survivors: a Prospective Cohort Study.
    Tao H; O'Neil A; Choi Y; Wang W; Wang J; Wang Y; Jia Y; Chen X
    Front Endocrinol (Lausanne); 2020; 11():60. PubMed ID: 32132977
    [No Abstract]   [Full Text] [Related]  

  • 16. Type 2 diabetes and the risk of mortality among patients with prostate cancer.
    Bensimon L; Yin H; Suissa S; Pollak MN; Azoulay L
    Cancer Causes Control; 2014 Mar; 25(3):329-38. PubMed ID: 24384808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of bivalirudin in patients receiving clopidogrel therapy after diagnostic angiography for percutaneous coronary intervention in acute coronary syndromes.
    Feldman DN; Minutello RM; Bergman G; Moussa I; Wong SC
    Catheter Cardiovasc Interv; 2010 Oct; 76(4):513-24. PubMed ID: 20882655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleeding, mortality, and antiplatelet therapy: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.
    Berger JS; Bhatt DL; Steg PG; Steinhubl SR; Montalescot G; Shao M; Hacke W; Fox KA; Berger PB; Topol EJ; Lincoff AM
    Am Heart J; 2011 Jul; 162(1):98-105.e1. PubMed ID: 21742095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative cohort study on personalised antiplatelet therapy in PCI-treated patients with high on-clopidogrel platelet reactivity. Results of the ISAR-HPR registry.
    Mayer K; Schulz S; Bernlochner I; Morath T; Braun S; Hausleiter J; Massberg S; Schunkert H; Laugwitz KL; Kastrati A; Sibbing D
    Thromb Haemost; 2014 Aug; 112(2):342-51. PubMed ID: 24718389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of very low on-treatment platelet reactivity in patients treated with thienopyridine: the POBA study (predictor of bleedings with antiplatelet drugs).
    Cuisset T; Grosdidier C; Loundou AD; Quilici J; Loosveld M; Camoin L; Pankert M; Beguin S; Lambert M; Morange PE; Bonnet JL; Alessi MC
    JACC Cardiovasc Interv; 2013 Aug; 6(8):854-63. PubMed ID: 23968703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.